logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
M

Marcus Ballinger

Genentech Inc.
H指数:39
被引数:1.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Digital Versus Manual PD-L1 Scoring in Advanced Non-Small Cell Lung Cancer From the IMpower110 and IMpower150 Trials

数字与人工PD-L1评分在晚期非小细胞肺癌中的应用比较：基于IMpower110和IMpower150试验

Journal of Thoracic Oncology
IF20.8
2025-08-050
PRE
Roy S. Herbst; Hen Prizant; Daniel Ruderman; Jake Conway; John Shamshoian; Hartmut Koeppen; Wei Zou; Filippo de Marinis; Giuseppe Giaccone; Jacek Jassem; David R. Spigel; Mark A. Socinski; Martin Reck; Luciana Molinero; Marcus Ballinger; David Shames; Michael Griffin; Limin Yu; Nishant Agrawal; Andrew Beck; Ilan Wapinski; Stephanie Hennek; Jennifer Giltnane; Minu K. Srivastava
RNA-seq molecular subtypes and gene expression signatures in the phase 3 IMpower151 study of 1L bevacizumab plus pemetrexed/paclitaxel ± atezolizumab in metastatic NSCLC
CANCER RESEARCH
IF16.6
2024-04-050
PRE
Zhou, Caicun; Sun, Charlie; Huang, Stacey; Dong, Xiaorong; Chen, Gongyan; Wang, Zhehai; Wu, Xianghua; Yao, Yu; Zhang, Yiping; Cheng, Ying; Pan, Hongming; Zhang, Xiaodong; Cui, Jiuwei; Wang, Lifeng; Chen, Xi; Li, Xiaoling; Wang, Ziping; Wang, Qiming; He, Jianxing; Wang, Mengzhao; Qian, Li; Hamidi, Habib; Li, Shanshan; Ballinger, Marcus; Shames, David S.; Srivastava, Minu
Comparison of SP263 and 22C3 immunohistochemistry PD-L1 assays for clinical efficacy of adjuvant atezolizumab in non-small cell lung cancer: results from the randomized phase III IMpower010 trial
JOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
2023-10-304
OAAI
Zhou, Caicun; Srivastava, Minu K.; Xu, Hao; Felip, Enriqueta; Wakelee, Heather; Altorki, Nasser; Reck, Martin; Liersch, Rudiger; Kryzhanivska, Anna; Oizumi, Satoshi; Tanaka, Hiroshi; Hamm, John; McCune, Steven L.; Bennett, Elizabeth; Gitlitz, Barbara; McNally, Virginia; Ballinger, Marcus; McCleland, Mark; Zou, Wei; Das Thakur, Meghna; Novello, Silvia
Late-differentiated effector neoantigen-specific CD8+T cells are enriched in peripheral blood of non-small cell lung carcinoma patients responding to atezolizumab treatment

晚期分化效应新抗原特异性CD8 T细胞在对阿特珠单抗治疗有反应的非小细胞肺癌患者的外周血中富集

JOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
2019-09-1262
OAAI
Fehlings, Michael; Jhunjhunwala, Suchit; Kowanetz, Marcin; O'Gorman, William E.; Hegde, Priti S.; Sumatoh, Hermi; Lee, Boon Heng; Nardin, Alessandra; Becht, Etienne; Flynn, Susan; Ballinger, Marcus; Newell, Evan W.; Yadav, Mahesh
Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti-PD-L1)

NSCLC中免疫细胞和肿瘤细胞对PD-L1表达的差异调节以及对阿特珠单抗治疗的反应 (anti-PD-L1)

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
IF9.1
2018-10-08189
OAAI
Kowanetz, Marcin; Zou, Wei; Gettinger, Scott N.; Koeppen, Hartmut; Kockx, Mark; Schmid, Peter; Kadel, Edward E., III; Wistuba, Ignacio; Chaft, Jamie; Rizvi, Naiyer A.; Spigel, David R.; Spira, Alexander; Hirsch, Fred R.; Cohen, Victor; Smith, Dustin; Boyd, Zach; Miley, Natasha; Flynn, Susan; Leveque, Vincent; Shames, David S.; Ballinger, Marcus; Mocci, Simonetta; Shankar, Geetha; Funke, Roel; Hampton, Garret; Sandler, Alan; Amler, Lukas; Mellman, Ira; Chen, Daniel S.; Hegde, Priti S.
Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab
NATURE MEDICINE
IF50
2018-08-06938
PREAI
Gandara, David R.; Paul, Sarah M.; Kowanetz, Marcin; Schleifman, Erica; Zou, Wei; Li, Yan; Rittmeyer, Achim; Fehrenbacher, Louis; Otto, Geoff; Malboeuf, Christine; Lieber, Daniel S.; Lipson, Doron; Silterra, Jacob; Amler, Lukas; Riehl, Todd; Cummings, Craig A.; Hegde, Priti S.; Sandler, Alan; Ballinger, Marcus; Fabrizio, David; Mok, Tony; Shames, David S.

研究方向

暂未获取到该数据
D
David S. Shames
H 指数:65论文数:312被引数:1.9万
R
René Bruno
H 指数:39论文数:172被引数:5,915
W
Wei Zou
H 指数:25论文数:100被引数:8,903
P
Priti S. Hegde
H 指数:51论文数:341被引数:3.3万
M
Marcin Kowanetz
H 指数:57论文数:248被引数:3.0万
D
Daniel S. Chen
H 指数:38论文数:109被引数:4.6万
B
Benjamin Wu
H 指数:22论文数:86被引数:1,757
D
David R. Gandara
H 指数:100论文数:1,118被引数:5.4万
M
Minu K. Srivastava
H 指数:22论文数:111被引数:2,816
A
Alan Sandler
H 指数:55论文数:221被引数:4.3万